Gisele Zapata-Sudo

Prof. Dr. Gisele Zapata-Sudo

Universidade Federal do Rio de Janeiro

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
ASAlexandre G. Silva
Alexandre G. Silva
GZGisele Zapata-Sudo
Gisele Zapata-Sudo
Arthur KümmerleArthur Kümmerle
Arthur Kümmerle
Carlos FragaCarlos Fraga
Carlos Fraga
EBEliezer J Barreiro
Eliezer J Barreiro
RSRoberto T. Sudo
Roberto T. Sudo

1 October 2009 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Arthur KümmerleArthur Kümmerle
Arthur Kümmerle
JRJuliana M Raimundo
Juliana M Raimundo
CLCarla M Leal
Carla M Leal
GSGivanildo S Da Silva
Givanildo S Da Silva
TBTatiane L Balliano
Tatiane L Balliano
EBEliezer J Barreiro
Eliezer J Barreiro

3 October 2017 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
LMLucas de Mendonça
Lucas de Mendonça
NFNathane S. Felix
Nathane S. Felix
NBNatália G. Blanco
Natália G. Blanco
JSJaqueline Da Silva
Jaqueline Da Silva
TFTatiana P. Ferreira
Tatiana P. Ferreira
PSPedro Silva
Pedro Silva
Experimental research has reported beneficial effects of mesenchymal stromal cell (MSC) therapy in pulmonary arterial hypertension (PAH). However, these studies either were based on prophylactic protocols or assessed basic remodeling features without evaluating possible mechanisms. We analyzed the effects of MSC therapy on lung vascular remodeling and hemodynamics and its possible mechanisms of action in monocrotaline (MCT)-induced PAH. Twenty-eight Wistar rats were randomly divided into two groups. In the PAH group, animals received MCT 60 mg/kg intraperitoneally, while a control group received saline (SAL) instead. On day 14, both groups were further randomized to receive 105 adipose-derived MSCs or SAL intravenously (n = 7/group). On day 28, right ventricular systolic pressure (RVSP) and the gene expression of mediators associated with apoptosis, inflammation, fibrosis, Smad-1 levels, cell proliferation, and endothelial–mesenchymal transition were determined. In addition, lung histology (smooth muscle cell proliferation and plexiform-like injuries), CD68+ and CD163+ macrophages, and plasma levels of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) were evaluated. In the PAH group, adipose-derived MSCs, compared to SAL, reduced mean RVSP (29 ± 1 vs 39 ± 2 mmHg, p < 0.001), lung tissue collagen fiber content, smooth muscle cell proliferation, CD68+ macrophages, interleukin-6 expression, and the antiapoptotic mediators Bcl-2 and survivin. Conversely, expression of the proapoptotic mediator procaspase-3 and plasma VEGF increased, with no changes in PDGF. In the pulmonary artery, MSCs dampened the endothelial–mesenchymal transition. In MCT-induced PAH, MSC therapy reduced lung vascular remodeling, thus improving hemodynamics. These beneficial effects were associated with increased levels of proapoptotic markers, mesenchymal-to-endothelial transition, reduced cell proliferation markers, and inflammation due to a shift away from the M1 phenotype.

4 April 2012 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
RPRamon Peçanha
Ramon Peçanha
LBLuiza de Lima e Silva Bagno
Luiza de Lima e Silva Bagno
MRMarcelo Baldanza Ribeiro
Marcelo Baldanza Ribeiro
Anna Beatriz FerreiraAnna Beatriz Ferreira
Anna Beatriz Ferreira
MMMilton Ozório Moraes
Milton Ozório Moraes
JCJoao Pedro Werneck de Castro
Joao Pedro Werneck de Castro
Background: The aim of the present study was to investigate whether adipose-derived stem cells could contribute to skeletal muscle-healing. Methods: Adipose-derived stem cells of male rats were cultured and injected into the soleus muscles of female rats. Two and four weeks after injections, muscles were tested for tetanic force (50 Hz). Histological analysis was performed to evaluate muscle collagen deposition and the number of centronucleated muscle fibers. In order to track donor cells, chimerism was detected with use of real-time polymerase chain reaction targeting the male sex-determining region Y (SRY) gene. Results: Two weeks after cell injection, tetanus strength and the number of centronucleated regenerating myofibers, as well as the number of centronucleated regenerating myofibers, were higher in the treated group than they were in the control group (mean and standard error of the mean, 79.2 ± 5.0% versus 58.3 ± 8.1%, respectively [p < 0.05]; and 145 ± 36 versus 273 ± 18 per 103 myofibers, respectively [p < 0.05]). However, there were no significant differences at four weeks. Treatment did not decrease collagen deposition. Male gene was not detected in female host tissue at two and four weeks after engraftment by polymerase chain reaction analysis. Conclusions: Adipose-derived stem-cell therapy increased muscle repair and force at two weeks, but not four weeks, after injection, suggesting that adipose-derived stem-cell administration may accelerate muscle repair; however, the rapid disappearance of injected cells suggests a paracrine mechanism of action.

15 December 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
SSSusumu Zapata Sudo
Susumu Zapata Sudo
Tadeu MontagnoliTadeu Montagnoli
Tadeu Montagnoli
Bruna RochaBruna Rocha
Bruna Rocha
Aimeé SantosAimeé Santos
Aimeé Santos
MSMauro P. L. de Sá
Mauro P. L. de Sá
GZGisele Zapata-Sudo
Gisele Zapata-Sudo
Cardiovascular autonomic neuropathy (CAN) is a severe complication of the advance stage of diabetes. More than 50% of diabetic patients diagnosed with peripheral neuropathy will have CAN, with clinical manifestations including tachycardia, severe orthostatic hypotension, syncope, and physical exercise intolerance. Since the prevalence of diabetes is increasing, a concomitant increase in CAN is expected and will reduce quality of life and increase mortality. Autonomic dysfunction is associated with reduced baroreflex sensitivity and impairment of sympathetic and parasympathetic modulation. Various autonomic function tests are used to diagnose CAN, a condition without adequate treatment. It is important to consider the control of glucose level and blood pressure as key factors for preventing CAN progression. However, altered biomarkers of inflammatory and endothelial function, increased purinergic receptor expression, and exacerbated oxidative stress lead to possible targets for the treatment of CAN. The present review describes the molecular alterations seen in CAN, diagnosis, and possible alternative treatments.

1 June 1996 in Anesthesiology
Verified
Journal Article
Open access
PDF file
TNThomas E. Nelson
Thomas E. Nelson
MLMarina Lin
Marina Lin
GZGisele Zapata-Sudo
Gisele Zapata-Sudo
RSRoberto Takashi Sudo
Roberto Takashi Sudo
Background: Dantrolene sodium (DS) is a direct-acting skeletal muscle relaxant whose only known action is to block calcium release from intracellular storage sites. The exact site of action for DS is unknown, but its efficacy in treating and preventing anesthetic-induced malignant hyperthermia (MH) is well established. Methods: Single ryanodine (Ry1) receptor calcium release channels were incorporated into a planar lipid bilayer for electrophysiologic recording and for subsequent analysis of the channel's gating and conductance properties. The cellular effects of low DS concentrations were investigated by isometric contracture tension responses in biopsied MH human and dog muscle fascicles and in normal, single fibers from human vastus lateralis muscle. Results: Two concentration-dependent DS effects on the isolated Ry1 receptor were discovered, suggesting at least two different binding sites. At nanomolar concentrations, DS activated the channel by causing three-to fivefold increases in open-state probability and dwell times. At micromolar concentrations, DS first increased then reduced activity in the channels; with the dominant effect being reduced activity. A 20 nm concentration of DS produced significant contracture tension in human muscle from one MH subject and caused potentiation of twitch in muscle from another MH patient. Halothane contracture in MH dog muscle was followed by an additional increase in tension when treated with 20 nm DS. Other investigations on chemically skinned, human fibers showed that calcium loaded in the sarcoplasmic reticulum was partially released by nM DS. Conclusions: The study results suggest that at least two binding sites for DS exist on the Ry1 receptor calcium channel. A low-affinity (microM) site is associated with reduced channel gating and open-state dwell time and may relate to the established pharmacologic muscle relaxant effect of DS. The proposed high-affinity (nM) DS binding site activates the channel, producing Ca2+ release to the myoplasm, which, under environmentally adverse conditions, could damage genetically predisposed MH muscle. Such a phenomenon, if it occurs in DS treated MH patients, could generate a recrudescence of the syndrome.